Literature DB >> 17265101

Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata.

Ana E Pérez-Matos1, William Rosado, Nadathur S Govind.   

Abstract

The Caribbean tunicate, Ecteinascidia turbinata produces the anti-cancer agent ET-743 that could well be a metabolite of an associated bacterial strain. This current study aims at the analysis of bacteria that are persistently and specifically associated with this invertebrate. Utilizing techniques such as denaturing gradient gel electrophoresis, DNA sequencing and phylogenetic analysis of bacteria from E. turbinata collected from different locations in the Caribbean Sea, we report here the identification of five possible persistently associated bacteria. Of these, only one organism, Candidatus Endoecteinascidia frumentensis, was found specifically associated to E. turbinata from the Caribbean and has also been found to be associated with E. turbinata from the Mediterranean. These experiments suggest that assessment of bacterial diversity associated with invertebrates from different geographical sites might be an effective way of identifying persistently and specifically associated bacteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265101     DOI: 10.1007/s10482-007-9143-9

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  23 in total

Review 1.  Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.

Authors:  William H Gerwick; Bradley S Moore
Journal:  Chem Biol       Date:  2012-01-27

2.  Biosynthetic origin of natural products isolated from marine microorganism-invertebrate assemblages.

Authors:  T Luke Simmons; R Cameron Coates; Benjamin R Clark; Niclas Engene; David Gonzalez; Eduardo Esquenazi; Pieter C Dorrestein; William H Gerwick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

Review 3.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

4.  Down under the tunic: bacterial biodiversity hotspots and widespread ammonia-oxidizing archaea in coral reef ascidians.

Authors:  Patrick M Erwin; Mari Carmen Pineda; Nicole Webster; Xavier Turon; Susanna López-Legentil
Journal:  ISME J       Date:  2013-10-24       Impact factor: 10.302

5.  Composition of Bacterial Communities Associated with Aurelia aurita Changes with Compartment, Life Stage, and Population.

Authors:  Nancy Weiland-Bräuer; Sven C Neulinger; Nicole Pinnow; Sven Künzel; John F Baines; Ruth A Schmitz
Journal:  Appl Environ Microbiol       Date:  2015-06-26       Impact factor: 4.792

6.  Species specificity of symbiosis and secondary metabolism in ascidians.

Authors:  Ma Diarey B Tianero; Jason C Kwan; Thomas P Wyche; Angela P Presson; Michael Koch; Louis R Barrows; Tim S Bugni; Eric W Schmidt
Journal:  ISME J       Date:  2014-08-29       Impact factor: 10.302

Review 7.  Life in cellulose houses: symbiotic bacterial biosynthesis of ascidian drugs and drug leads.

Authors:  Eric W Schmidt; Mohamed S Donia
Journal:  Curr Opin Biotechnol       Date:  2010-11-01       Impact factor: 9.740

Review 8.  Parallel lives of symbionts and hosts: chemical mutualism in marine animals.

Authors:  Maho Morita; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2018-04-25       Impact factor: 13.423

9.  Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743.

Authors:  Christopher M Rath; Benjamin Janto; Josh Earl; Azad Ahmed; Fen Z Hu; Luisa Hiller; Meg Dahlgren; Rachael Kreft; Fengan Yu; Jeremy J Wolff; Hye Kyong Kweon; Michael A Christiansen; Kristina Håkansson; Robert M Williams; Garth D Ehrlich; David H Sherman
Journal:  ACS Chem Biol       Date:  2011-09-20       Impact factor: 5.100

Review 10.  Development of novel drugs from marine surface associated microorganisms.

Authors:  Anahit Penesyan; Staffan Kjelleberg; Suhelen Egan
Journal:  Mar Drugs       Date:  2010-03-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.